Researchers evaluate peer-reviewed literature on interventions to improve vaccine uptake among thousands of US adults studied between 2010 and 2015.
|Articles|December 19, 2005
Depakote ER OK'd for symptoms of bipolar disorder
Advertisement
The FDA has given the nod to Abbott's Depakote ER (divalproex sodium) tablets for the treatment of mania or mixed episodes with or without psychotic features associated with bipolar disorder. Depakote ER is the once-daily formulation of Depakote tablets, which has been a treatment for bipolar disorder since its approval in 1995.
Advertisement
Related to this article
Infectious disease readiness depends on rehearsed workflows, bidirectional public health communication, and rapid access to care.
Pharmacist pain clinics typically focus on comprehensive medication management involving the entire patient scenario.
A case shows a suspected recurrence of pneumococcal disease that ended with removal of one cochlear implant and replacement of the other.
Detailed phase 3 data show retatrutide lowered body weight and A1C over 80 weeks for patients with diabetes and obesity.
In celebration of the organization’s recent convention, NCPA released its annual digest report for members, providing a detailed overview of independent community pharmacy.
Local collaborations can turn pharmacies into care-coordination hubs, but lasting results require trained teams, shared data, and sustainable payment.
In a rapidly evolving diabetes and obesity management landscape, Brian Smith, PharmD, discusses approaches that are helping patients maximize their outcomes on GLP-1 therapy.
Advertisement
Advertisement
Trending on Drug Topics
1
From Binder to Action: Making Infectious Disease Outbreak Plans Operational
2
Retatrutide Delivers 20.8% Weight Loss in Adults With Type 2 Diabetes
3
Addressing Medication Adherence in Cardiometabolic Health
4
Pharmacist Pain Management Clinics: The Expert as the Pain Coach
5